Aristada and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported only by a few people who take Aristada.

The phase IV clinical study analyzes which people take Aristada and have Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 3,511 people who have side effects while taking Aristada from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

3,511 people reported to have side effects when taking Aristada.
Among them, 3 people (0.09%) have Chronic obstructive pulmonary disease.


What is Aristada?

Aristada has active ingredients of aripiprazole lauroxil. eHealthMe is studying from 3,517 Aristada users for its effectiveness, alternative drugs and more.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,687 drugs and 2,003 conditions by eHealthMe.

Number of Aristada and Chronic obstructive pulmonary disease reports submitted per year:

Could Aristada cause Chronic obstructive pulmonary disease?

Gender of people who have Chronic obstructive pulmonary disease when taking Aristada *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Chronic obstructive pulmonary disease when taking Aristada *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common side effects people have besides Chronic obstructive pulmonary disease *:

  1. Pericardial Effusion (fluid around the heart): 3 people, 100.00%
  2. Oedema Peripheral (superficial swelling): 3 people, 100.00%
  3. Breathing Difficulty: 3 people, 100.00%
  4. Blood Glucose Abnormal: 3 people, 100.00%
  5. Weight Increased: 2 people, 66.67%
  6. Sleep Apnea Syndrome: 2 people, 66.67%
  7. Oropharyngeal Pain: 2 people, 66.67%
  8. Lung Disorder (lung disease): 2 people, 66.67%
  9. Injection Site Pain: 2 people, 66.67%
  10. Hypersensitivity: 2 people, 66.67%

Common conditions people have *:

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 100.00%
  2. High Blood Pressure: 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Aristada and have Chronic obstructive pulmonary disease?

Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Chronic obstructive pulmonary disease and when was it recovered:

Expand to all the drugs that have ingredients of aripiprazole lauroxil:

Alternative drugs to, pros and cons of Aristada:

Common Aristada side effects:

Browse all side effects of Aristada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic obstructive pulmonary disease treatments and more:

COVID vaccines that are related to Chronic obstructive pulmonary disease:

Common drugs associated with Chronic obstructive pulmonary disease:

All the drugs that are associated with Chronic obstructive pulmonary disease:

Common conditions associated with Chronic obstructive pulmonary disease:

All the conditions that are associated with Chronic obstructive pulmonary disease:

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole lauroxil (the active ingredients of Aristada) and Aristada (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: